Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Al Jalila Children’s Genomics Center, |
RCV001732231 | SCV001984655 | likely benign | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2020-06-02 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001732231 | SCV003799291 | uncertain significance | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2023-11-22 | criteria provided, single submitter | clinical testing | The PLOD1 c.173C>T; p.Ser58Phe variant (rs534978828), also known as c.77-3358C>T in transcript NM_000302.4, is not reported in the medical literature or gene-specific databases, to our knowledge. This variant is found in the non-Finnish European population with an overall allele frequency of 0.24% (296/120954 alleles) in the Genome Aggregation Database. The serine at codon 58 is weakly conserved, and computational analyses predict that this variant is neutral (REVEL: 0.004). This variant occurs in a weakly conserved exon that is expressed at low levels in the Genotype-Tissue Expression (GTEx) database (see link), suggesting it may not occur in physiologically relevant transcript. However, given the lack of clinical and functional data, the significance of the p.Ser58Phe variant is uncertain at this time. References: Link to PLOD1 in GTEx Portal: https://www.gtexportal.org/home/gene/PLOD1 |
Prevention |
RCV003968491 | SCV004779546 | likely benign | PLOD1-related disorder | 2022-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001702293 | SCV001932291 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702293 | SCV001972327 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome |
RCV001732231 | SCV002074945 | not provided | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 04-23-2020 by Lab or GTR ID 239772. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |